Skip to content

CDR

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s Laboratories and its subsidiary, Promius Pharma. today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA). Tosymra is indicated for the acute treatment of migraine with or without aura in adults.

Rite Aid announces plans for reverse stock split

Rite Aid announces plans for reverse stock split

CAMP HILL, PA – Rite Aid Corp. announced today that its board of directors has approved a reverse stock split of the company’s common stock. The reverse stock split is intended to enable Rite Aid to regain full compliance with the New York Stock Exchange (NYSE) listing rules.

Pepsi to launch new nitrogen-infused drink called “Nitro Pepsi”

Pepsi to launch new nitrogen-infused drink called “Nitro Pepsi”

Pepsi has announced the roll out of a nitrogen-infused version of its trademark soda called “Nitro Pepsi.” With a promising “velvety, cascading foam,” Nitro Pepsi aims to replicate that drinking experience as the “world’s first nitrogen-infused soda” in two flavors: Classic Soda and Vanilla.

NACDS demonstrates need for DIR fee reform in comments to CMS

NACDS demonstrates need for DIR fee reform in comments to CMS

Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to refor

CVS announces organizational changes

CVS announces organizational changes

CVS Pharmacy has expanded the responsibilities of Judy Sansone, the chain’s senior vice president of front store business and chief merchant. In addition, George Coleman has been promoted to senior vice president of merchandising, reporting to Sansone.

BD launches ergonomic pen needle technology

BD launches ergonomic pen needle technology

BD (Becton, Dickinson and Company), announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano pen needle, designed for more reliable subcutaneous injection depth.